Domyn has launched Domyn Large, a 260-billion-parameter reasoning model tailored for regulated industries, introduced via Microsoft Foundry on April 15.
Backed by G42, the company is also exploring fresh funding while targeting sectors such as banking, pharmaceuticals, government, and defence, where data sovereignty and controlled deployment are critical.
Uljan Sharka has outlined a $10bn investment roadmap over three years to build a large-scale supercomputing initiative in Italy in partnership with NVIDIA and G42.
A core element of Domyn’s positioning is enabling enterprises to retain full ownership of their AI systems, including models, data, and infrastructure, within compliant and governed environments.
Domyn Large is built for mission-critical enterprise use, offering configurable reasoning capabilities, advanced integrations, and alignment with the EU AI Act. It supports more than 50 languages and allows organisations to enhance performance continuously using proprietary datasets through iterative pretraining.
The company is already seeing early traction across sectors such as banking, insurance, utilities, and aerospace. Key applications include fraud detection and transaction monitoring in financial services, claims automation and risk analysis in insurance, and optimisation across industrial operations.
Microsoft Foundry is positioned as a unified environment for building and scaling AI agents, bringing together models, tools, data, and observability. Domyn’s integration into this ecosystem provides access to enterprise customers prioritising governance, security, and scalable deployment.
G42 has previously outlined plans for a major compute cluster in Italy, powered by thousands of advanced GPUs and operated through Core42, to support sovereign AI workloads across Europe. While initial estimates pointed to a $1bn phase, Domyn’s broader $10bn ambition signals a significant expansion in infrastructure investment.
NVIDIA has also highlighted its collaboration with Domyn in developing an AI factory powered by next-generation GPUs. The company’s Colosseum infrastructure is designed to support models exceeding one trillion parameters, reinforcing the role of high-performance computing in scaling enterprise AI adoption.
Healthcare is a key focus area, with Domyn emphasising capabilities that enable pharmaceutical firms to run parallel simulations and accelerate research cycles.
While future AI architectures may reduce dependence on concentrated compute, the near-term strategy remains centred on scaling infrastructure and sustaining capital investment.
